pillbase.ru

Itovebi

Active substance: inavolisib

inavolisib

Centralised EU authorisationActive

Marketing holder: Roche Registration GmbH 

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Itovebi
    TABLET, FILM COATED · INAVOLISIB 3 mg/1
    50242-084
    Genentech, Inc.
  • Itovebi
    TABLET, FILM COATED · INAVOLISIB 9 mg/1
    50242-079
    Genentech, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-305d-7198-b801-b224b1672032,01a1208f-cb3f-79aa-8304-e8a7d4ca6768;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006353
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/006353 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006353 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006353 · Verified 2026-10-09